Congressional Research Service Reports - 206 Matching Results

Search Results

2016 Rio Games: Anti-Doping Testing: This report discusses the the anti-doping testing program during the 2016 Summer Olympics. Responsibility for the rests with the International Olympic Committee (IOC). The testing period began July 24, 2016, when the Olympic village opened, and continues through August 21, 2016, the date of the closing ceremony.
Actions of the Congress and the Federal Government on Smoking and Health: This paper is a history of actions taken by the U.S. Congress and by the various departments and regulatory agencies of the Federal Government on the subject of smoking and health for the period from the mid-1950s to the end of the 95th Congress in 1978.
Active Opioid Legislation in the House: In Brief: This report briefly summarizes opioid-related bills that were considered during "Opioid Week" (the week of May 9, 2016) The summaries in this report may be useful illustrations of the range of approaches Members of Congress have proposed to address the problem of opioid addiction.
Afghanistan: Narcotics and U.S. Policy: Opium poppy cultivation and drug trafficking have eroded Afghanistan's fragile political and economic order over the last 30 years. This report provides current statistical information, profiles the narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report provides current statistical information, profiles the Afghanistan narcotics trade's participants, explores linkages between narcotics, insecurity, and corruption, and reviews U.S. and international policy responses since late 2001. The report also considers ongoing policy debates regarding the counternarcotics role of coalition military forces, poppy eradication, alternative livelihoods, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: In addition to describing the structure and development of the Afghan narcotics trade, this report provides current statistical information, profiles the trade's various participants, explores alleged narco-terrorist linkages, and reviews U.S. and international policy responses since late 2001. The report also considers current policy debates regarding the role of the U.S. military in counternarcotics operations, opium poppy eradication, alternative livelihood development, and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report describes the structure and development of the narcotics trade in Afghanistan and explores its relevance to Afghan, U.S., and international security interests, including the 9/11 Commission’s recommendation that the United States make a long term commitment to the stability and security of Afghanistan. The report provides current statistical information on the opium trade, profiles its various participants, explores alleged narco-terrorist linkages, and reviews the U.S. and international policy response since late 2001. The report also considers current policy debates regarding the role of the U.S. military in future counternarcotics operations in Afghanistan; planned opium poppy eradication; and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report describes the structure and development of the narcotics trade in Afghanistan and explores its relevance to Afghan, U.S., and international security interests, including the 9/11 Commission’s recommendation that the United States make a long term commitment to the stability and security of Afghanistan. The report provides current statistical information on the opium trade, profiles its various participants, explores alleged narco-terrorist linkages, and reviews the U.S. and international policy response since late 2001. The report also considers current policy debates regarding the role of the U.S. military in future counternarcotics operations in Afghanistan; planned opium poppy eradication; and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report describes the structure and development of the narcotics trade in Afghanistan and explores its relevance to Afghan, U.S., and international security interests, including the 9/11 Commission’s recommendation that the United States make a long term commitment to the stability and security of Afghanistan. The report provides current statistical information on the opium trade, profiles its various participants, explores alleged narco-terrorist linkages, and reviews the U.S. and international policy response since late 2001. The report also considers current policy debates regarding the role of the U.S. military in future counternarcotics operations in Afghanistan; planned opium poppy eradication; and funding issues for Congress.
Afghanistan: Narcotics and U.S. Policy: This report describes the structure and development of the narcotics trade in Afghanistan and explores its relevance to Afghan, U.S., and international security interests, including the 9/11 Commission’s recommendation that the United States make a long term commitment to the stability and security of Afghanistan. The report provides current statistical information on the opium trade, profiles its various participants, explores alleged narco-terrorist linkages, and reviews the U.S. and international policy response since late 2001. The report also considers current policy debates regarding the role of the U.S. military in future counternarcotics operations in Afghanistan; planned opium poppy eradication; and funding issues for Congress.
Andean Counterdrug Initiative (ACI) and Related Funding Programs: FY2005 Assistance: This report discusses the funds and material support the U.S. has contributed to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999.
Andean Counterdrug Initiative (ACI) and Related Funding Programs: FY2006 Assistance: This report discusses the funds and material support the U.S. has contributed to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999.
Andean Counterdrug Initiative (ACI) and Related Funding Programs: FY2007 Assistance: This report discusses the funds and material support the U.S. has contributed to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999.
ATPA Renewal: Background and Issues: The Andean Trade Preference Act (ATPA) extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities. This report outlines the various aspects of the ATPA, including significant dates and modifications.
ATPA Renewal: Background and Issues: This report outlines the various aspects of the Andean Trade Preference Act (ATPA), including significant dates and modifications. The ATPA extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities.
ATPA Renewal: Background and Issues: The Andean Trade Preference Act (ATPA) extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities. This report outlines the impact and policy implications of the ATPA.
ATPA Renewal: Background and Issues: The Andean Trade Preference Act (ATPA) extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities. This report outlines the various aspects of the ATPA, including significant dates and modifications.
ATPA Renewal: Background and Issues: The Andean Trade Preference Act (ATPA) extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. This report outlines the various aspects of the ATPA, including significant dates and modifications.
ATPA Renewal: Background and Issues: This report outlines the various aspects of the Andean Trade Preference Act (ATPA), including significant dates and modifications. The ATPA extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities.
ATPA Renewal: Background and Issues: The Andean Trade Preference Act (ATPA) extends special duty treatment to certain U.S. imports from Bolivia, Colombia, Ecuador, and Peru that meet domestic content and other requirements. The purpose of ATPA is to promote economic growth in the Andean region and to encourage a shift away from dependence on illegal drugs by supporting legitimate economic activities. This report outlines the various aspects of the ATPA, including significant dates and modifications.
Buprenorphine and the Opioid Crisis: A Primer for Congress: This report addresses questions policymakers may have about the effectiveness of the opioid addiction treatment drug buprenorphine, the demand for buprenorphine, and access to buprenorphine.
Cigarette Taxes to Fund Health Care Reform: An Economic Analysis: A cigarette excise tax increase of 75 cents per pack has been proposed to finance part of the President's universal health care program. The tax enjoys considerable public support, would raise about $11 billion per year, and would be relatively simple to administer because it would increase an existing manufacturer's excise tax. This report discusses these rationales, as well as other effects of and concerns about the tax, organized into topics of market failure as a justification for the tax (i.e., economic efficiency); potential for revenue; equity; and the job loss the tax might cause in tobacco growing regions.
Colombia: Issues for Congress: Recent debate on U.S. policy toward Colombia has taken place in a context of concern for the volume of drugs readily available in the United States and elsewhere in the world, and regional security issues. The United States has made a significant commitment of funds and material support to help Colombia and the Andean region fight drug trafficking since the development of Plan Colombia in 1999. Congress passed legislation providing $1.3 billion in assistance for FY2000 (P.L. 106-246) and has provided more than $4 billion for programs in Colombia from FY2000 through FY2005 in both State Department and Defense Department counternarcotics accounts.
Colombia: The Problem of Illegal Narcotics and U.S. - Colombian Relations: The United States has long been concerned with Colombia as a major producer and trafficker of the illegal narcotics entering this country: first marijuana, then cocaine, and now also heroin. Colombia's drug trafficking business has been dominated by two cartels during the two decades in which cocaine trafficking became a major activity: first the Medellin cartel, which dominated during the 1980s and then the Cali cartel, which dominated during the early 1990s. With the arrests of the major Cali cartel leaders in the mid-1990s, independent traffickers have filled the void.
The Comprehensive Addiction and Recovery Act of 2016 (S. 524): Comparison of Senate- and House-Passed Versions: This report discusses selected differences and similarities between the Senate- and House-passed versions of the Comprehensive Addiction and Recovery Act of 2016 (CARA; S. 524), which aims to address the problem of opioid addiction in the United States. The two versions of the bill differ substantially. The scope of the differences may be illustrated by their structures: The Senate bill has 28 sections organized in 8 titles, whereas the House bill has 69 sections organized in 18 titles.
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits: This report gives an overview of the issues related to federal or state laws that condition the initial or ongoing receipt of governmental benefits on passing drug tests. These regulations are vulnerable to constitutional challenge, most often due to issues of personal privacy and Fourth Amendment protections against "unreasonable searches."
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits: This report provides an overview of the Fourth Amendment in order to effectively evaluate the constitutionality of laws requiring suspicionless drug tests to receive governmental benefits. It then reviews five Supreme Court decisions that have evaluated these programs. The report concludes with a synthesis of the various factors that likely will be important to a future court's assessment of the constitutionality of these laws.
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits: This report gives an overview of the issues related to federal or state laws that condition the initial or ongoing receipt of governmental benefits on passing drug tests. These regulations are vulnerable to constitutional challenge, most often due to issues of personal privacy and Fourth Amendment protections against "unreasonable searches."
Control of Drug Abuse : Summary of Principal Legislative Activity in the 93rd Congress: This report collects Federal government efforts to control drug abuse in the United States.
Control of Illicit Traffic in Dangerous Drugs: Suppression of illicit traffic is only one aspect of the general Federal Government effort to prevent the abuse of narcotics and other dangerous drug;, but in political significance it is undoubtedly paramount. Various approaches to the problem have been suggested and tried since the first explicitly anti-opium law was enacted in 1887.
Coordination of Federal Efforts to Control Illicit Drug Traffic: This report discusses how best to coordinate the Federal government's multi-agency efforts to curb illicit traffic in dangerous drugs has once again become an issue of major interest to the Congress. Critics of the Reagan Administration's anti-drug program contend that it lacks an overall strategy and that it suffers from the absence of a central mechanism for the formulation of general policy as well as for the broad direction of operations
Developments in the Right of Privacy: Whalen v. Roe and the Extent of the Right to Anonymity in the Doctor-Patient Relationship: This report outlines the question of privacy between doctor and patient and the potential abuse of prescription drugs without state and federal intervention.
Drug Abuse and Minority Groups in the United States: Selected References: This bibliography is a collection of published works concerning minority groups and drug abuse in the United States.
Drug Abuse in the Military: Selected References 1970-1972: This bibliography collects published works on drug abuse in the United States Military published from 1970 to 1972.
Drug abuse office and treatment act of 1972(s.2097; P.L 92-255):Summary of major provisions: This report addresses the drug abuse office and treatment act of 1972.
Drug Certification of Mexico in 1999: Arguments For and Against Congressional Resolutions of Disapproval: This report presents arguments for and against congressional resolutions to disapprove President Clinton’s February 26, 1999 certification of Mexico as a fully cooperative country in efforts to control illicit narcotics.1 These resolutions (H.J.Res. 35--Bachus, and H.J.Res. 43--Mica and Gilman) would disapprove the President’s certification, but would permit him to avoid withholding of assistance to Mexico if he determined that vital national interests required such assistance.
Drug Certification Requirements and Congressional Modifications in 2001: This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Congressional Modifications in 2001-2002: This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Congressional Modifications in 2001-2002: This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Certification Requirements and Proposed Congressional Modifications in 2001: This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
Drug Control: How to prevent the non-medical use of dependency-producing drugs has been a public policy concern for at least a century. A large part of the responsibility for controlling such substances has been assumed by the Federal Government. Historically based on decision to restrict availability through a system of close regulation, including selective prohibition, the current Federal anti-drugs strategy lives on activities and programs in five major areas: 1) regulation and other “enforcement” efforts; 2) support for international control and for control efforts of individual drug-producing and drug-transiting countries; 3) education and other prevention activities; 4 ) treatment and rehabilitation for drug-dependent persons; and ( 5 ) research on drugs , drug dependency, and prevention and treatment methods.
Drug Control: International Policy and Approaches: This report discusses various U.S. international narcotics policy approaches meant to achieve two main goals: to reduce the supply of illicit narcotics flowing into the United States, and to reduce the amount of illicit narcotics cultivated, processed, and consumed worldwide.

Congressional Research Service Reports - 206 Matching Results

Search Results

Add Filters

Applied Filters